ENvue Medical (FEED) Gross Profit Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 5.02% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.10% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 4.54% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 15.44% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 9.03% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.15% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 17.49% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 1.49% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 8.46% |
| 10 | ENvue Medical | 2.97 Mn | 709,615.89 | -55,000.00 | -30.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -30.73% |
| Dec 31, 2025 | -7.24% |
| Sep 30, 2025 | 33.19% |
| Jun 30, 2025 | -28.56% |
| Mar 31, 2025 | 51.56% |
| Dec 31, 2024 | 3.26% |
| Sep 30, 2024 | -16.45% |
| Jun 30, 2024 | 27.19% |
| Mar 31, 2024 | 105.07% |
| Dec 31, 2023 | 204.91% |
| Sep 30, 2023 | 52.19% |
| Jun 30, 2023 | 78.47% |
| Mar 31, 2023 | 66.40% |
| Dec 31, 2022 | -125.97% |
| Sep 30, 2022 | 19.40% |
| Jun 30, 2022 | 10.72% |
| Mar 31, 2022 | 25.99% |
| Dec 31, 2021 | 138.26% |
| Sep 30, 2021 | 205.46% |
| Jun 30, 2021 | 39.27% |
| Mar 31, 2021 | 11.87% |
| Dec 31, 2020 | -11.88% |
| Sep 30, 2020 | 32.05% |
| Jun 30, 2020 | 3.78% |
| Mar 31, 2020 | 12.31% |
| Dec 31, 2019 | -38.98% |
| Sep 30, 2019 | 11.40% |
| Jun 30, 2019 | 72.97% |
| Mar 31, 2019 | 20.89% |
| Dec 31, 2018 | -8.74% |
| Sep 30, 2018 | -35.63% |
| Jun 30, 2018 | 47.49% |
| Mar 31, 2018 | 42.52% |
| Dec 31, 2017 | -2.50% |
| Sep 30, 2017 | 84.69% |
| Jun 30, 2017 | -4.47% |
| Mar 31, 2017 | 42.60% |